BRAVE: Building Resilience and Values Through E-health

The purpose of this study is to determine the feasibility and acceptability of tracking survivors' and their caregivers, stressors, affect, and symptoms using an electronic diary method, in the time period surrounding their routine check- up with their oncologist.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Survivorship

Age range

11 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University

San Francisco, California, 94305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

11-25 years old
previously received a pediatric cancer diagnosis and treatment for such
completed cancer treatment <5 years ago, in remission
Own a smart phone or tablet
are English proficient

Exclusion criteria

no cognitive, motor, or sensory deficits that could preclude completion of study measures.

Treatment and study plan

Online survey questionnaire

Other

Participants will complete a brief online survey every morning and evening within 1 hour of waking and 1 hour of going to sleep. The surveys will be a combination of measures used to assess affect, stress, and symptoms

Primary outcomes

Online survey questionnaire

Time frame: 21 days

participants will complete a brief online survey every morning and evening within 1 hour of waking and 1 hour of going to sleep

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Feb 7, 2022
Registry last updated: Sep 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed